RxSight (RXST) Shares Outstanding (2020 - 2026)

RxSight (RXST) has 7 years of Shares Outstanding data on file, last reported at $41.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 1.96% year-over-year to $41.4 million; the trailing twelve-month figure through Mar 2026 stood at $41.4 million (up 1.96% YoY), and the FY2025 full-year result was $41.2 million, up 2.01% from the prior year.
• Shares Outstanding for Q1 2026 stood at $41.4 million, roughly flat from $41.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $41.4 million in Q1 2026 and bottomed at $27.5 million in Q1 2022.
• The 5-year median for Shares Outstanding is $37.2 million (2024), against an average of $36.2 million.
• Peak annual rise in Shares Outstanding reached 571.37% in 2022, while the deepest fall reached 1.45% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $28.3 million in 2022, then increased by 27.84% to $36.1 million in 2023, then increased by 11.87% to $40.4 million in 2024, then gained by 2.01% to $41.2 million in 2025, then increased by 0.34% to $41.4 million in 2026.
• The last three Shares Outstanding figures came in at $41.4 million (Q1 2026), $41.2 million (Q4 2025), and $41.1 million (Q3 2025), per Business Quant data.

Peer Comparison